Shanghai Mental Health Center
Quick facts
| Founded | 1935 |
|---|
Marketed products
- amisulpride with Clozapine
- Donepezil and Lithium · Neurology/Psychiatry
Donepezil inhibits acetylcholinesterase to increase acetylcholine levels in the brain, while lithium modulates intracellular signaling pathways and neuroprotection. - fluoxetine + Amfebutamone · Psychiatry / Mental Health
This combination enhances monoamine neurotransmission by inhibiting serotonin reuptake (fluoxetine) and inhibiting norepinephrine and dopamine reuptake (amfebutamone). - Lithium carbonate + perospirone hydrochloride · Psychiatry
Lithium carbonate modulates intracellular signaling pathways to stabilize mood, while perospirone hydrochloride acts as an atypical antipsychotic by blocking dopamine and serotonin receptors. - Lithium Carbonate Pill · Psychiatry
Lithium carbonate modulates intracellular signaling pathways, particularly inhibiting inositol monophosphatase and glycogen synthase kinase-3 (GSK-3), which stabilizes mood and reduces manic and depressive episodes. - Lithium+fluvoxamine · Psychiatry
Lithium enhances mood stabilization through effects on intracellular signaling, while fluvoxamine increases serotonin availability by inhibiting its reuptake, together targeting mood disorders through complementary neurochemical pathways. - Mirtazapine/SNRIs · Psychiatry/Mental Health
Mirtazapine is a tetracyclic antidepressant that blocks alpha-2 adrenergic receptors and serotonin 5-HT2 and 5-HT3 receptors, increasing norepinephrine and serotonin neurotransmission. - Perospirone hydrochloride tablets · Psychiatry/Neurology
Perospirone is an atypical antipsychotic that blocks dopamine D2 receptors and serotonin 5-HT2A receptors in the brain. - Placebo plus Lithium · Psychiatry
Lithium modulates intracellular signaling pathways, particularly inhibiting glycogen synthase kinase-3 (GSK-3) and affecting monoamine neurotransmitter systems to stabilize mood. - placebo with Clozapine · Psychiatry
Clozapine is an atypical antipsychotic that blocks dopamine and serotonin receptors in the brain to reduce psychotic symptoms. - sodium valproate with Clozapine · Psychiatry
This combination pairs sodium valproate (a histone deacetylase inhibitor and GABA enhancer) with clozapine (an atypical antipsychotic) to provide synergistic effects on mood stabilization and antipsychotic activity. - toludesvenlafaxine hydrochloride sustained-release tablets · Psychiatry / Mental Health
Toludesvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases synaptic levels of serotonin and norepinephrine by blocking their reuptake at the presynaptic membrane.
Phase 3 pipeline
- Anyu Peibo · Psychiatry
Anyu Peibo is a medication used to treat depression. - Intramuscular Haloperidol · Psychiatry
Haloperidol is a typical antipsychotic that blocks dopamine D2 receptors in the brain to reduce psychotic symptoms and agitation. - Octohydroaminoacridine Succinate · Neurology
Octohydroaminoacridine succinate is a cognitive enhancer that likely increases acetylcholine levels in the brain by inhibiting acetylcholinesterase. - Phase 1: Amisulpride · Psychiatry
Amisulpride is a selective dopamine D2 and D3 receptor antagonist that blocks dopamine signaling in the brain to reduce psychotic symptoms and improve mood. - Phase 1: Aripiprazole · Psychiatry
Aripiprazole is a dopamine D2/D3 receptor partial agonist that modulates dopaminergic and serotonergic neurotransmission in the brain. - Phase 1: Olanzapine · Psychiatry
Olanzapine is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors in the brain. - Phase 1: Perphenazine · Psychiatry
Perphenazine is a typical antipsychotic that blocks dopamine D2 receptors in the brain to reduce psychotic symptoms. - Phase 1: Risperidone · Psychiatry
Risperidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors in the brain. - Phase 2: Amisulpride · Psychiatry
Amisulpride is a selective dopamine D2 and D3 receptor antagonist that blocks dopamine signaling in the brain to reduce psychotic symptoms and improve mood. - Phase 2: Clozapine · Psychiatry
Clozapine is an atypical antipsychotic that blocks dopamine D2 receptors and serotonin 5-HT2A receptors in the brain. - Phase 2: Olanzapine · Psychiatry
Olanzapine is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors in the brain. - Phase 3B: Clozapine or another SGAs · Psychiatry
Clozapine and other second-generation antipsychotics block dopamine and serotonin receptors in the brain to reduce psychotic symptoms and improve mood regulation.
Phase 2 pipeline
- Augment with Aripiprazole · Psychiatry / Neurology
Aripiprazole is a partial agonist at dopamine D2 and serotonin 5-HT1A receptors that modulates dopaminergic and serotonergic neurotransmission in the brain. - Augment with Memantine · Neurology
Augment with Memantine is a combination of a glutamate receptor antagonist and a NMDA receptor antagonist, which may help to improve cognitive function in patients with Alzheimer's disease. - bear bile pill
- conventional mood stabilizers
- Dayingpian · Other
- Generic Escitalopram
- Innovator Escitalopram · Neurology
Selective serotonin reuptake inhibitor - Intramuscular Levosulpiride
- Lemborexant tablets · Neurology
Treats insomnia by modulating orexin receptors - Orcinoside · Other
- Xiongdan Wan
- Yuxintine · Other
Phase 1 pipeline
- Aripiprazole with Clozapine
- Drug: fluoxetine
- methadone maintenance treatment
- Risperidone with Clozapine
- Toludivenlafaxine hydrochloride sustained-release tablets
- Traditional Chinese Medicine JITAI
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Shanghai Mental Health Center
What are Shanghai Mental Health Center's marketed drugs?
Top marketed products include amisulpride with Clozapine, Donepezil and Lithium, fluoxetine + Amfebutamone, Lithium carbonate + perospirone hydrochloride, Lithium Carbonate Pill, Lithium+fluvoxamine.
What is Shanghai Mental Health Center's pipeline?
Shanghai Mental Health Center has 12 drugs in Phase 3, 12 in Phase 2, 6 in Phase 1. Late-stage candidates include Anyu Peibo, Intramuscular Haloperidol, Octohydroaminoacridine Succinate, Phase 1: Amisulpride.
When was Shanghai Mental Health Center founded?
Shanghai Mental Health Center was founded in 1935.
Related
- amisulpride with Clozapine
- Donepezil and Lithium · Neurology/Psychiatry
- fluoxetine + Amfebutamone · Psychiatry / Mental Health
- Lithium carbonate + perospirone hydrochloride · Psychiatry
- Lithium Carbonate Pill · Psychiatry
- Sector hub: All tracked pharma companies